Stay updated on ELiSA Study: Lixivaptan in ADPKD Clinical Trial
Sign up to get notified when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.

Latest updates to the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the study record content remains unchanged.SummaryDifference0.1%

- Check23 days agoChange DetectedA banner announces the NIH website transition and says the agency is adopting “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.5%

- Check30 days agoChange DetectedThe footer identifies the ClinicalTrials.gov site as revision v3.7.2 rather than v3.7.1.SummaryDifference0.1%

- Check37 days agoChange DetectedThe site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed from the current history view.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed from the history list. This updates the visible revision trail to reflect the latest change to the record.SummaryDifference0.1%

Stay in the know with updates to ELiSA Study: Lixivaptan in ADPKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.